Chapter 6: Breast Lumps & Nipple Discharge Assessment

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Hello and welcome back to another edition of the Deep Dive.

Hello.

Today we are opening up a file that, I'll be honest,

carries a lot of emotional weight.

It's universally anxiety inducing for patients and it can be incredibly, you know, clinically complex for the provider.

It really can.

We are looking squarely at chapter six of advanced health assessment and clinical diagnosis in primary care.

The topic is breast lumps and nipple discharge.

It is a heavy topic, you're right, but it's also one of those areas where your skill as a clinician, your actual hands -on technique, and really your ability to ask the right questions, it makes a tangible life -altering difference.

That's a great way to put it.

We aren't just memorizing facts today.

We're talking about the art of symptom analysis,

the physical exam dance, and the logic behind the differential diagnosis.

Exactly.

And our mission today is very specific.

We want to decode the clinical reasoning behind evaluating these complaints.

So whether you're a nursing student, a medical resident, or just someone trying to understand how a clinician's brain works, we are going to walk through that logic step by step.

And I want to start with a statistic from the text that honestly stopped me in my tracks.

I had to read it twice.

I have a feeling I know exactly which one you're looking at.

Is it the detection rate?

It is the detection rate.

The text explicitly states that up to 90 % of all breast lumps are found by the patient or their partner, not by the clinician during a routine exam.

90%.

It's a staggering number.

It really is.

And think about what that implies for a second.

We spend years training to palpate, to feel, to detect.

But the reality is a patient is living in that body every single day.

They notice the change first.

They know their own normal.

Exactly.

And it completely reframes how we approach this chapter.

If the patient is the one finding the problem nine times out of 10, then the patient's history, their story of how they found it, how long it's been there, becomes the most powerful tool in your diagnostic kit.

So it's not like you're just hunting for something hidden?

No, not at all.

You are investigating a specific lead they are handing to you.

That puts the patient in the driver's seat of the initial discovery and us in the seat of the investigator.

Precisely.

And the stakes are high.

When we look at breast lumps, we are essentially trying to differentiate between what the text calls the big three.

The big three.

You have fibrodinomas, you have fibrocystic changes, and you have carcinoma.

And obviously one of those is everyone patient and provider is afraid of.

Right.

We can't ignore the gravity of it.

Breast carcinoma is the most common cancer in women and the second leading cause of cancer -related death.

So every assessment has this underlying tension.

Of course.

However, and this is the massive but we need to hold onto throughout this entire episode, benign conditions are far, far more common.

That's the reassurance part.

It is.

Fibrocystic changes,

cysts, fibrodinomas, these happen constantly.

They are, for many people, part of the normal variation of life.

So the goal isn't just find cancer.

It's rule out cancer so we can manage everything else appropriately.

Exactly.

The text puts it perfectly.

The goal of the assessment process is to reach a diagnosis that addresses the possibility of breast cancer.

Even though benign is more likely, the logic must always be structured to safely, definitively rule out malignancy.

You assume the worst until you prove the best.

That's the mindset.

Yeah.

Okay.

Let's trip away the anxiety for a minute and focus on that cold hard logic.

Let's put on our detective hats.

A patient comes into your clinic, they sit down, they look worried and they say, I found a lump.

What is the very first thing we need to do?

You keep your hands in your pockets.

Okay.

Don't jump to the exam.

Don't jump to the exam.

You start with the focused history.

Before you even touch the patient, you need to ask the core questions.

The text outlines a specific set of interrogatives that narrow down the field immediately.

Hit me with them.

What are we asking?

There are four pillars here.

First is duration.

How long has it been there?

Simple enough.

Second is trajectory.

Is it changing?

Is it getting bigger, worse or more painful?

Third is location.

Is this happening in one breast or both?

Unilateral or bilateral?

And fourth, and this is crucial, is the hormonal context.

When was the last menstrual period?

Okay.

Let them tack those because they seem simple, but the answers, I imagine, tell you a lot.

Let's talk about the suspicious lump first.

If I'm a clinician, what specific description makes the hair on the back of my neck stand up?

So the textbook profile of a malignant lesion is very specific.

You are looking for a solitary lump, just one.

Not multiple lumps.

No, a single one.

It is typically hard, often described as stone -hard painless,

and this is the key.

It is unchanged by the menstrual cycle.

So it doesn't ebb and flow with hormones.

It just sits there.

It sits there and it progresses.

Malignant lumps tend to show a progressive increase in size.

They don't fluctuate.

They grow.

They grow until they actually alter the contour of the breast tissue.

It's a relentless slow march.

Okay.

That's the scary profile.

That's the red alert.

What's the reassuring profile?

What do you hear that makes you, you know, breathe a sigh of relief?

Well, contrast that stone -hard growing lump with a lump that has been present for years without changing.

If a patient says, oh, that bump, I've had that for five years.

It's never changed size.

That is almost always benign.

Stability is good.

Stability is excellent.

Malignancy doesn't usually stay the same size for five years.

And here's a fascinating rule of thumb from the text regarding new lumps.

It's called the rule of halves.

I loved this part.

The rule of halves.

Break it down for us.

It's a brilliant little clinical pearl.

It states that half of all newly appearing benign cysts will resolve on their own within two or three menstrual cycles.

That is wild.

So 50 % of these benign things just disappear if you give them a couple of months.

Right.

They are physiologic.

They are responding to the hormonal tides of the body.

They swell up and then they go away.

Which is exactly why understanding the menstrual cycle is part of the history taking.

Absolutely.

If a woman comes in with a tender lump right before her period, it might just be the physiological cycle at work, but a hard painless rock that ignores her cycle.

That's a whole different story.

Okay.

Let's talk about that one breast versus both breasts dynamic.

You mentioned location is a core question.

Why does it matter if it's bilateral?

This is the symmetry rule.

Generally speaking, physiological changes, hormonal stuff, it affects the whole body.

Right.

It didn't pick and choose.

Your hormones don't usually just target the left breast and ignore the right.

So if you find lumps bilaterally, especially if they're in identical quadrants of the breast, say the upper outer quadrant on both sides, that is highly likely to be benign fibrocystic change.

Because cancer rarely strikes in the exact same spot on both sides at the exact same time.

Exactly.

It's not impossible, but it's statistically very, very unlikely.

A solitary unilateral lump is the red flag.

Now keep in mind that unilateral lump could still be a cyst or a fibrodinoma.

It's not a death sentence.

Not at all, but it demands investigation in a way that symmetrical lumpiness might not.

Got it.

Symmetry is safety, usually.

Asymmetry is suspicion.

Now we can't talk about breast lumps without talking about age.

The text breaks this down beautifully.

It seems like age acts as a massive diagnostic filter.

It really does.

You can almost categorize your differential diagnosis just by looking at the patient's birth year before you even walk in the room.

Let's run through the brackets.

Let's say the patient is under 30, young woman.

What's the top suspect?

Under 30, your top suspect is a fibrodinoma.

These are benign solid tumors.

They are very common in that, say, 15 to 30 age range.

They're distinct mobile rubbery.

Okay.

What about that 20 to 30 range?

You start to see a crossover.

You still see fibrodinomas, but you see a lot of cystic changes there, too.

That's that heterogeneous group of cysts, nodularity, tenderness that comes and goes with the cycle.

Moving up 35 to 55.

Now we're entering the perimenopausal years.

The hormones are starting to fluctuate wildly.

Here you start seeing things like intradoccal papilloma and ductectasia conditions often associated with discharge, which we'll get to.

The plumbing is starting to get a little backed up.

That's a good way to put it.

The plumbing is starting to get a little blocked up, so to speak.

And then 40 to 70.

That is the peak prevalence for carcinoma.

The risk rises steadily with age and accelerates rapidly after age 50.

This is the danger zone where your index of suspicion has to be highest.

But there's a clinical pearl here that the text emphasizes for everyone, regardless of the most likely bracket.

It's a safety net.

Yes.

The text is very, very clear on this.

Any patient older than 25 who presents with a

needs evaluation.

Any patient.

Any patient.

That means a clinical breast exam or CBE and likely imaging mammogram, ultrasound, or both.

You don't just say, oh, you're 26, it's probably fine.

You have to verify.

Right.

You verify.

You don't guess.

That feels like the motto for this whole chapter.

It should be the motto for primary care in general.

Let's move to part two of our investigation.

Pain, timing, and special populations.

I think there was a myth out there.

I certainly grew up hearing it, that if it doesn't hurt, it's cancer.

But the text says something different about pain or nostalgia.

It's actually often the opposite.

Pain is frequently a sign of benign hormonal activity.

Yeah.

The most frequent breast complaint is a painful mobile lump that grows and gets more tender right before a period.

That is classic fibrocystic change.

The breast tissue is retaining water.

It's swelling.

It's pushing on nerve endings.

It hurts.

So pain can be reassuring.

In that specific context of a cycling woman, yes.

However, and there is always a however in medicine, we have to look at the post -menopausal population.

Ah, the rules change after menopause.

They do.

In a post -menopausal patient, unilateral breast pain, just hurting on one side,

actually increases the risk of cancer.

So wait,

in a 25 -year -old, cyclic pain is normal.

But in a 65 -year -old, new one -sided pain is a red flag.

That's the critical distinction.

Context is everything.

Wow.

Okay.

Let's talk about another specific context, implants.

Augmentation is incredibly common now.

The text had a very specific note about how to spot a rupture.

Yes.

You will see this in primary care.

If an implant ruptures, the text notes that the augmented tissue often gets pushed away from the chest wall.

You might feel masses or changes in shape.

And how do you best feel that?

Interestingly, the text suggests these masses are often best palpated with the patient in the sitting position rather than lying down.

Why sitting?

Gravity, again.

It helps differentiate the capsule of the implant from the breast tissue itself.

You're trying to feel if the bag, so to speak, feels different or has moved.

Okay.

Good practical tip.

Now, I want to talk about pregnancy and lactation, because this is where things can get scary fast if you are paying attention.

We've all heard of mastitis.

Right.

Mastitis is inflammation of the breast tissue, usually involving a blocked duct and an infection.

It's classic in breastfeeding mothers.

The text says it typically shows up on day two or three postpartum, often caused by staph aureus.

It looks like what?

It looks angry.

Red, hot, painful, swollen, usually just one sector of the breast.

And the patient often feels terrible fever, chills, body aches.

It's an infection.

Okay.

So a nursing mom comes in, red hot breast.

You think mastitis.

You treat for mastitis with antibiotics.

But the text issues a massive warning here.

There is a lookalike.

This is one of the most important takeaways from this chapter.

If you remember nothing else, remember this.

You have to watch out for inflammatory breast cancer.

It mimics mastitis.

Almost perfectly.

The breast is swollen, heavy, edematous, often described as looking like an orange peel or peau d 'orange.

It's red and inflamed.

It looks exactly like a bad infection.

So how do you tell the difference?

A cue.

How do you not miss cancer thinking it's a clogged duct?

Two main clues.

First, inflammatory breast cancer often occurs in non -lactating women.

If a woman isn't breastfeeding and her breast suddenly looks like it has mastitis, you should be very, very worried.

Okay, that's a big one.

A huge one.

Second, inflammatory breast cancer rarely has a fever.

Infectious mastitis usually comes with a fever because it's a bacterial infection.

Cancer is inflammation, not infection.

So, red breast, no baby, no fever equals danger.

Danger.

High danger.

And the rule is strict.

If you treat a patient for mastitis with antibiotics and it doesn't clear up, or if there's a mass remaining after the infection has gone, you must biopsy.

No exceptions.

No exceptions.

You cannot assume it was just a stubborn infection.

You have to rule out inflammatory carcinoma.

That is life -saving advice right there.

Never assume it's cleared up until you've checked.

It moves fast, so you have to move fast.

Let's slide into part three, risk factor analysis.

We've established that anyone over 25 gets checked,

but we need to know who is at high risk.

The host in me wants to believe that if I eat right and exercise and don't have it in my family, I'm safe.

But the text, it bursts that bubble immediately.

It does, and it's a sobering statistic.

The text states 70 % to 80 % of breast cancers occur in patients with NO risk factors.

I need you to say that again.

That's astounding.

70 % to 80%.

That means the vast majority of women who get breast cancer do not have a family history, do not have the genetic mutations, do not have the high -risk profile.

They are just women living their lives.

That implies that the absence of risk factors means absolutely nothing when you are staring at a lump.

Correct.

Risk factors help us raise our index of suspicion, but the lack of them does not protect the patient.

You can't say, oh, you have no family history, so this lump is probably fine.

That is false logic.

That is how diagnoses get missed.

Okay, so everyone is at risk, but some are at higher risk.

Let's look at box 6 .1 in the text.

What pushes a patient into the high -risk category?

Age is the biggest one.

We mentioned 75 % of cases occur after age 50.

Then you have personal history.

If a patient has had breast cancer before or DCIS ductal carcinoma, in situ, their risk is significantly higher.

Their tissue has already proven it can make errors.

In family history, we hear about this a lot.

What's the specific definition?

We do.

Specifically, we are looking for first -degree relatives.

So mother, sister, daughter.

Mother, sister, daughter, or having two or more close relatives even if they aren't first -degree.

And the genetic mutations?

BRCA1 and BRCA2.

Presence of these mutations obviously skyrockets the risk.

These are the genes responsible for repairing DNA damage.

If they are broken, cancer happens much more easily.

The text also listed some other cancers that seem to correlate.

Yes, this is the Lynch syndrome or hormonal connection.

A personal history or family history of ovarian, endometrial, colon, or thyroid cancer correlates with higher breast cancer risk.

It's all connected.

There was one more risk factor that felt very technical.

Biopsy history.

This is nuanced, but important.

If a patient has had a biopsy in the past for a benign condition,

the results of that biopsy matter.

So not just that they had one, but what it showed.

Exactly.

If they had atypical hyperplasia, which means the cells were starting to look a little weird, a little disorganized, but weren't cancer yet, that increases their future risk by four to five times.

If they had LCIS, lobular carcinoma, in situ, the risk is eight to ten times higher.

So past biopsies are part of the current history.

Absolutely.

You need to know what was found in those previous lumps.

You need to chase down those pathology reports.

Okay, moving on to part four.

Nipple discharge.

This is another symptom that causes huge anxiety, but the text says it's actually quite common and usually benign.

It is, but like lumps, it requires a systematic approach to categorize it.

We look at the discharge and ask three main things.

Is it spontaneous or expressed?

Is it one side or both?

And crucially, what color is it?

Let's start with spontaneous versus expressed.

What's the difference?

Spontaneous means it comes out on its own.

Maybe they find it on their bra or sleepwear.

That is more concerning.

And expressed.

Expressed means it only comes out when the nipple is squeezed or manipulated.

Expressed discharge is usually less concerning and often physiologic.

Okay, and color.

The text gives us a bit of a color decoder ring.

It does.

Let's start with milky.

If it's milky and the patient isn't breastfeeding, it's likely galacturia.

This is often hormonal, specifically elevated prolactin.

Then there's the green -brown sticky stuff, which sounds awful.

It sounds unpleasant, but ironically, the grosser it looks, often the more benign it is.

That is the hallmark of duct ectasia.

Duct ectasia.

Yeah.

This happens in older women where the ducts get blocked with debris and inflammatory cells.

It's sticky and multicolored green, black, brown.

It's essentially duct sludge.

Duct sludge.

Got it.

And the one we worry about.

Serous clear or serosanguineous bloody.

Clear or bloody discharge, especially if it is unilateral and spontaneous, is the most suspicious.

And what causes that?

The number one cause is actually benign and intradectal papilloma, which is a little wart -like growth inside the duct, but it can also be intraductal cancer.

So bloody discharge mandates a workup.

You mentioned medications earlier.

The text had a laundry list of drugs that can cause nipple discharge.

I was surprised by some of them.

It's a long list because anything that messes with dopamine can mess with prolactin.

Dopamine keeps prolactin in check.

So if you block dopamine, prolactin goes up.

Milk comes out.

So tranquilizers, phenothiazines, methyl dopa, certain antidepressants, even oral contraceptives can cause a clear or milky discharge.

And then there are the lifestyle causes.

Jogger's nipple.

Yes.

Jogger's nipple.

Mechanical chafing from running without a sports bra or protective tape can irritate the nipple enough to cause discharge.

It's purely mechanical irritation.

And stimulation.

This is a feedback loop.

Frequent sexual stimulation or, and we see this often,

anxious patients constantly squeezing their nipples to check for discharge can actually cause the discharge.

So the check creates the symptom.

Sometimes, yes.

You have to tell patients,

stop checking, leave it alone for two weeks and see if it stops.

One last weird one from the text.

Newborns.

Which is milk.

A very old term.

Newborns of either sex can have enlarged breasts and white discharge.

It's because of the mother's estrogens still circulating in the baby system.

It disappears in one to two weeks.

Totally normal.

Good to know so parents don't panic.

It's just mom's hormones leaving the building.

Exactly.

All right.

We have the history.

We have the risk factors.

Now we have to touch the patient.

Part five.

The physical examination.

The text makes it clear.

You don't just have the patient lie down and poke around.

It's a multiposition inspection.

It's a performance almost.

You need to inspect the breasts in four positions to really see the anatomy.

First, sitting with arms at sides, then arms overhead.

Why overhead?

What does that show you?

It pulls the tissue up.

It highlights dimpling or retraction that might be hidden when the skin is slack.

If a tumor is tethering the skin, lifting the arms will show a dimple.

Okay.

Position three.

Hands on hips, pushing in.

Pushing the hands into the hips contracts the pectoralis muscles.

If a deep tumor is fixed to the muscle, the skin over it will dimple or retract when that muscle flexes.

It reveals fixation.

You're testing the slide of the tissue over the muscle.

Precisely.

And position four.

Leaning forward.

Gravity.

You want to see if the breasts hang symmetrically.

If one is held back or pulled askew, it suggests something is tethering it internally.

While we were looking, what skin signs are we hunting for?

You mentioned peau d 'orange earlier.

Yes.

The orange peel look edema caused by blocked lymphatics.

Also look for erythema, which is redness or prominent unilateral veins.

If one breast has big bulging veins and the other doesn't, it could mean a tumor is demanding increased blood flow.

Because tumors are vascular sponges.

That's a great way to think of it.

Yes.

And Paget disease.

Paget disease is sneaky.

It looks like eczema on the nipple.

Crusting, scaling, a rash right on the nipple itself.

If you see eczema on a nipple, you don't just give hydrocortisone.

You worry about Paget disease, which is an external sign of an underlying ductal cancer.

So nipple eczema equals biopsy.

That's the rule.

Essentially, yes.

Until proven otherwise.

Now for the palpation technique.

The text is very prescriptive here.

We aren't just improvising.

No.

The patient should be supine.

And you want to flatten the breast tissue against the chest wall.

So if you are examining the right breast, the patient's right arm goes overhead.

And you might even put a towel under the scapula.

To thin out the tissue.

Exactly.

You can't find a marble in a thick duvet.

You need to spread the duvet out.

What are the boundaries?

Where does the breast stop?

It's bigger than people think.

It goes from the second or third rib down to the sixth or seventh.

And from the sternum all the way to the midaxillary line, the middle of the armpit.

And we cannot forget the tail of Spence.

Never forget the tail of Spence.

That is the tongue of breast tissue that extends up into the axilla, the armpit.

A lot of breast tissue lives there.

And a disproportionately high number of cancers are found in the upper outer quadrant, extending into that tail.

Talk to me about the finger technique.

Use the pads of your fingers, not the tips.

The tips are for poking.

Pads are for sensing.

And you use three depths at every single spot.

Three depths.

Light, medium, and deep.

You don't just press once.

You press lightly to feel the skin, medium for the middle tissue, and deep to feel against the ribs.

If you don't go deep, you miss the tumors sitting on the chest wall.

And the pattern.

Circles.

Wedges.

What's best?

The text specifically cites the vertical strip method as having the best evidence for accuracy.

So up and down.

Up and down, up and down, like mowing a lawn.

It ensures you don't miss a spot.

Concentric circles and wedges are used, but vertical strips are preferred because you cover 100 % of the surface area.

And the text says don't lift your fingers.

Right.

Collide from one spot to the next.

If you lift your hand, you might skip a centimeter of tissue, and that centimeter could hide a small lump.

Maintain contact.

There's a specific maneuver for the nipple, too.

The nipple well.

Yes.

At the end, you gently depress the tissue directly behind the nipple.

It should feel like a smooth, concave well.

If it feels full or resist, there might be a subriolar mass.

Let's talk lymph nodes.

We're in the armpit area anyway.

Which ones are we checking?

You need to check the axillary nodes, obviously.

But also the supraclavicular, which are above the collarbone, and enfraclavicular, which are below the collarbone.

What does a bad node feel like?

A bad node 1 suggestive of metastasis is usually larger than one centimeter.

It feels firm, hard, or matted, which means stuck together.

And it is often fixed to the chest wall.

It feels like a rock.

Versus a good or reactive node.

A reactive node, maybe from a shaving rick or a bug bite, is usually small, rubbery, mobile, and might be tender.

Mobile and rubbery is generally okay.

Hard and fixed is bad.

Finally, checking for discharge.

You could just squeeze everyone's nipples.

No, please don't.

The text says palpate for discharge only if the patient reports discharge.

If they report it, you gently compress to identify the source.

Does it come from a single duct?

That's suspicious.

Multiple ducts.

Usually systemic and benign.

But don't go looking for fluid that isn't volunteering itself.

Okay, we've done the exam.

We found something.

Now we need technology.

Part 6.

Diagnostic studies.

There's a very clear fork in the road depending on the patient's age.

The magic number is 30.

Why 30?

Breast density.

In women under 30, the breast tissue is typically very dense and glandular.

Mammograms struggle to see through that density.

It all looks white.

Like trying to find a polar bear in a snowstorm.

Exactly.

So for women 30 years, the first line of imaging is ultrasound.

Ultrasound is good for what, specifically?

It's excellent at distinguishing solid versus cystic.

Is this lump a bag of fluid, which is a cyst, or a chunk of tissue, which is solid?

And for women 30 years?

Then we move to mammography.

As we age, breast tissue becomes less dense and more fatty, which makes mammograms very effective at spotting masses and calcifications.

The text mentions tomosynthesis, which is 3D mammography, improves detection even more by creating slices of the image.

Where does MRI fit in?

I hear about that a lot.

MRI is the high -powered magnifying glass.

It has very high sensitivity.

It catches almost everything, like 85 to 100 percent.

But it has lower specificity.

It creates false alarms.

So it's too sensitive for general use.

Right.

It's used for screening high -risk women, like BRCA carriers, checking for implant ruptures, or evaluating dense tissue where a mammogram failed.

It's not the first line for everyone.

Once we have an image, we usually need tissue.

We need a biopsy.

The text defines three types, help us distinguish them.

FNA, core, excisional.

Okay.

FNA, fine needle aspiration, is using a tiny needle to suck out fluid or cells.

It's great for cysts.

If you stick a needle in a lump, draw out clear fluid, and the lump disappears.

Congratulations.

You just diagnosed and cured a cyst.

It's too done.

Yeah.

But if it's solid.

Yeah.

Then FNA can give you cells for cytology.

But a core needle biopsy is better.

It uses a larger needle to take a cylinder, a core of tissue.

This gives the pathologist more architecture to look at.

They can see how the cells are arranged, which is crucial for diagnosis.

And you go left.

Excisional biopsy, that's surgery.

You go to the OR and remove the entire lump.

You do this if the needle biopsies are inconclusive, or if the mass is large and needs to come out regardless.

Just a quick note on labs.

We mentioned prolactin earlier.

Yes.

If there is milky discharge, you check serum prolactin.

If it's super high, let's say over 250 NGML, you worry about a prolactinoma, which is a pituitary tumor, and you also check TSH.

Why TSH?

What does the thyroid have to do with it?

Because hypothyroidism can cause high prolactin.

The hormone TRH, thyroid -releasing hormone, also stimulates prolactin release.

So sometimes fixing the thyroid fixes the nipple discharge.

Incredible connectivity in the body.

It's all a web.

We are in the home stretch.

Part seven,

the differential diagnosis.

This is the cheat sheet.

I'm going to throw a condition at you, and I want the key features based on the text.

Let's distinguish the masses.

Ready.

Breast cancer.

Single lump,

hard,

fixed, so immobile, irregular borders, non -tender, most common in the outer quadrant,

and age usually over 40, 50.

Bobrodinoma.

The mouse of the breast, because it slips around under your finger.

Freely mobile, firm, round, non -tender, common in women under 30.

Softer fluctuant, which is like bouncy,

tender, changes size with the menstrual cycle, and a key trick, it trans -illuminates.

You can shine a light through it?

Yeah, if you shine a light through it in a dark room, it glows because it's fluid.

Fat necrosis.

This one is tricky.

The great pretender.

It feels hard and fixed, just like cancer, but the history is key.

Trauma.

A seatbelt injury, a bruise, a blow to the chest to create scar tissue.

You almost always have to biopsy it to prove it's not cancer.

Lipoma.

Just a fatty tumor.

Soft, non -tender, mobile,

boring, clinically speaking, which is good.

Infection pocket.

Red hot, tender, fluctuant, so it's pus -filled.

Usually associated with mastitis.

Introductal papilloma.

The number one cause of bloody discharge.

Usually a small unilateral lump behind the nipple.

Benign, but it needs removal.

Dictatasia.

Bilateral.

Green or brown, sticky discharge.

A history of blocked ducts in an older woman.

And finally, fibrocystic changes.

Multiple lumps.

Bilateral.

Cyclic tenderness that worsens right before the period.

It's a condition, not a disease.

That brings us to the end of chapter six.

We have gone from the patient's discovery of a lump, through the detective work of history -taking, the physical exam maneuvers, and the diagnostic tree.

It's a comprehensive roadmap.

It really is.

And if I can leave the listener with one final thought, it's this.

The normal breast is a complex, dynamic organ.

It changes with age, with cycles, with pregnancy.

It's not a static mannequin.

Far from it.

The text highlights that benign condition cysts,

Hormonal changes are incredibly common.

Our job as clinicians isn't just to hunt for the rare cancer.

It is to confidently reassure the majority of women who don't have cancer, while possessing the sharp clinical skills to catch the few who do.

It is a balance of vigilance and restraint.

Vigilance and restraint.

Like that.

We aren't looking for trouble, but we are ready if we find it.

Exactly.

This has been a deep dive into Advanced Health Assessment chapter six.

Thank you for learning with us.

Thank you.

A warm thank you from the Last Minute Lecture team.

We'll see you on the next dive.